Paladin Energy beats Q4 production and finishes FY26 at top of guidance
A second straight forecast-beating quarter and a completed ramp-up hand Paladin cautious optimism, but bearish brokers may need convincing.
Source: Shutterstock
Mentioned
KEY POINTS
- Paladin completed its Langer Heinrich ramp-up on schedule, with Q4 production comfortably ahead of estimates and full-year output finishing at the upper end of the guidance range.
- Costs and capex both came in below expectations through the quarter, though a softer average selling price took some shine off the operational performance.
- Shares edged higher, but brokers were bearish last quarter leaving the coming days to test whether this beat shifts sentiment.
Paladin Energy (PDN) is on a roll, notching a second straight quarter of forecast-beating production as Q4 output topped the market and FY26 settled at the top end of guidance following the completed Langer Heinrich ramp-up.
Paul Hemburrow, Managing Director and CEO, said: “We were very pleased to successfully complete the ramp-up of the Langer Heinrich Mine in line with our commitment to deliver this goal by the end of FY2026, while also meeting the upper-end of our revised production guidance.”
Paladin shares are up 3.7% to $8.88 at noon.
Beating guidance and expectations
Paladin Energy reported Q4 uranium production ahead of market expectations, with FY26 output at the upper end of guidance following the completed Langer Heinrich ramp-up.
Q4 numbers:
Uranium produced of 1.23Mlb vs 1.19Mlb ests (3% beat)
Uranium sold of 1.35Mlb vs 1.28Mlb ests (5% beat)
Average selling price of US$70.6/lb vs US$76.0 ests (7% miss)
Cost of production of $51.6/lb vs $53.8 ests (4% lower)
Capex of $5.1m vs $9.5m ests
Cash and investments of $265m vs $260.7m ests, plus an undrawn $70m revolving credit facility
FY26 numbers:
Production of 4.82Mlb topping guidance of 4.5-4.8Mlb
Sales of 4.35Mlb above 3.8-4.2Mlb guidance
Costs of $43.3/lb below the $44-48 guidance
Capex of $12.1m below $15-17m guidance
The company announced that its Patterson Lake South project advanced, with the Canadian Nuclear Safety Commission deeming the Construction Licence application sufficient to proceed and hearings targeted for end of calendar 2027.
Paladin also issued an FY27 production guidance of 5.1-5.6Mlb, which represents a year-on-year increase of 11% at the midpoint and 6% ahead of Macquarie's estimates (Apr-26) of 5.03Mlb.
Optimism ahead?
Posting positive results is surely no bad thing, but analysts stayed bearish despite the company beating production guidance at its March quarter report. On 20 April, Macquarie downgraded the stock to Neutral, though lifted its target from $13.50 to $13.55. The analysts said the stock had re-rated too far ahead of fundamentals, flagged FY27 production downside risks versus consensus, and saw better value elsewhere in uranium equities.
Paladin and the broader uranium sector have traded sharply lower over the past couple of months, with a barometer like the Global X Uranium ETF down 30% since early May. But now Paladin has topped Q4 and full-year expectations, along with FY27 production guidance that's ahead of Macquarie forecasts. The stock is trading 40% below mid-April levels, so it'll be interesting to see how analyst views change against a much cheaper valuation and still-solid backdrop for uranium prices.
